Hospira, Inc. recalls Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx o
Recalled December 26, 2012 · FDA recall D-099-2013 · Hospira
Hazard
Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product. · FDA Class II
Units
120,350 vials
Sold at
Nationwide
Description
Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.
Product
Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-4279-02.
Manufacturer(s)
Hospira, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →